Select your Market

[TITLE]

[TEASER]

Locations
[FULL TEXT]

Related News

  1. Press Releases

    Merck KGaA, Darmstadt, Germany, Announces First Patient Dosed in Phase 3 Study ...

    Phase 3 study is evaluating Precem-TcT for the treatment of metastatic colorectal cancer (mCRC).

    2026/05/21